Tenpoint Therapeutics GmbH

Swiss Biotech Association

Member

Tenpoint is a biotechnology company committed to advancing engineered cell-based therapies and in vivo reprogramming to restore vision for people with degenerative ocular diseases, bringing together the global experts shaping the regenerative ocular medicine revolution.

Products, services, technology

Engineered cell-based therapies and in vivo reprogramming to restore vision for people with degenerative ocular diseases.

Location

Aeschenvorstadt 4, 4051 Basel, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2020
Number of employees in Switzerland

10-19

Key business

Core competencies

You may also be interested in

CELLnTEC Advanced Cell Systems

CELLnTEC technologies enable science and industry to develop innovations in stem cell research, regenerative medicine, cell-based therapies, and beyond. The company is a pioneering developer of chemically defined, animal and human components-free precision media.
3014 Bern

Member

Caland SA

Caland SA provides a professional, confidential, competitive and impeccable service of pharma-grade CO2 extraction, distillation and cannabis formulation based on GMP requirements.
A modern production line, coupled to a qualified ERP, ensures uncompromising quality of all products and services.
2800 Delémont

Member

INCAPTEK Sàrl

We at INCAPTEK are developing advanced drug delivery systems. We deliver drugs at the right place, in the right dosage, and at the right time. Our smart, programmed-shell micro(nano)capsules can be used for controlled and targeted drug delivery for both biotech and medtech.
1204 Geneva

Member